Terminated PHASE1 INTERVENTIONAL 1-arm NCT01502605

Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Updated 6 times since 2017 Last updated: Jan 3, 2017 Started: Sep 30, 2012 Primary completion: May 31, 2015 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI leaving institution

Other terminated trials from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

See all terminations from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Other Astrocytoma trials with similar outcome

Browse all Astrocytoma trials

A PHASE1 clinical study on Astrocytoma and Glioma, this trial is terminated or withdrawn. The trial is conducted by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

Status: Completed → Terminated

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Data source: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States